DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Rebetol (Ribavirin) - Nausea - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Nausea (125)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rebetol (Ribavirin) where reactions include nausea. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 125   Next >>

Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Nausea

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-12
    End date: 2012-06-17

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-12
    End date: 2012-06-17

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-12
    End date: 2012-06-17

Other drugs received by patient: Talion (Bepotastine Besylate); Mucosta; Loxonin



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient:

Reactions: Myalgia, Injection Site Haemorrhage, Nausea, Chills, Sinus Headache, Hyperhidrosis, Muscle Spasms

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-22

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-22



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient:

Reactions: Haemoglobin Decreased, Dysgeusia, Nausea, Chills, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 microgram, qw

Rebetol
    Dosage: unk
    Administration route: Oral

Victrelis
    Dosage: unk
    Administration route: Oral

Other drugs received by patient: Protonix



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-27

Patient:

Reactions: Fatigue, Nausea, Headache

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw

Rebetol
    Administration route: Oral

Other drugs received by patient: Zyrtec; Lisinopril; Nortriptyline HCL; Atenolol; Prilosec; Estradiol



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-25

Patient:

Reactions: Nausea, Flatulence

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-29

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-29

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-27



Possible Rebetol side effects in 67 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24

Patient: 67 year old male

Reactions: Nausea, Neutrophil Count Decreased, Erythema, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegintron / 01543001 /
    Dosage: 1.5 a?g/kg, unk
    Indication: Hepatitis C
    Start date: 2012-02-24
    End date: 2012-06-12

Rebetol
    Dosage: 400 mg, unk
    Administration route: Oral
    Start date: 2012-03-27
    End date: 2012-06-03

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-24
    End date: 2012-02-28

Rebetol
    Dosage: 800 mg, unk
    Administration route: Oral
    Start date: 2012-03-02
    End date: 2012-03-26

Rebetol
    Dosage: 400 unk, unk
    Administration route: Oral
    End date: 2012-06-19

VX-950
    Dosage: 2250 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-24
    End date: 2012-02-28

Other drugs received by patient: Loxonin; Lansoprazole; Lansoprazole; Doxazosin Mesylate; Petrolatum Salicylate; Norvasc; Loxonin; Antebate Ointment; Aspirin; Diovan; Humalog; Lasix; Primperan TAB



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-24

Patient:

Reactions: Abdominal Pain, Oral Mucosal Blistering, Vomiting, LIP Blister, Nausea, Muscle Spasms

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Start date: 2012-08-17
    End date: 2012-08-19

Rebetol



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-24

Patient:

Reactions: White Blood Cell Count Decreased, Dyspnoea, Vomiting, RED Blood Cell Count Decreased, Nausea, Dizziness, Pallor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Dosage: 180 microgram, qw
    Indication: Hepatitis C
    Start date: 2011-10-21

Rebetol
    Dosage: 1200 mg, qd
    Indication: Hepatitis C
    Start date: 2011-10-21

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-10-21



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Renal Impairment, Vomiting, Nausea, Dizziness, General Physical Health Deterioration

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Glycyron
    Dosage: 6 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-07-04

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-16

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-12

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-04-13
    End date: 2012-04-16

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-16

Other drugs received by patient: Adalat CC; Olmesartan Medoxomil; Olmesartan Medoxomil; Loxonin; Loxonin; Adalat CC; Adalat CC; Glycyron; Doxazosin Mesylate; Metformin HCL; Kinedak; Adalat CC; Nesina; Loxonin; Potassium Chloride; Trichlormethiazide; Amaryl; Lendormin; Allopurinol; Trichlormethiazide; Vitamin E; Primperan TAB; Amaryl; Loxonin; Metformin HCL; Kinedak; Rohypnol; Doxazosin Mesylate; Nesina; Urso 250; Vitamin B12; Electrolytes (Unspecified) (+) Sodium Lactate; Lyrica; Lendormin D



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Nausea

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-11

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-05-31

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-06-01

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-07-06

Other drugs received by patient: Loxonin; Antebate



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Nausea, Decreased Appetite

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-03-29

Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-30
    End date: 2012-04-16

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-04-16

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-04-16

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-03-29

Telavic
    Administration route: Oral
    Start date: 2012-03-30
    End date: 2012-04-16

Other drugs received by patient: Levocarnitine Hydrochloride; Rabeprazole Sodium; Primperan TAB; L Cartin; Rebamipide



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient:

Reactions: Weight Decreased, Pneumonia, Pruritus, Dyspnoea, Nausea, Pain, Haemoglobin Abnormal, Irritability, Diplopia, Fatigue, Lung Disorder, Dizziness, Asthenia, Decreased Appetite, Influenza

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Rebetol
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Telaprevir
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Other drugs received by patient: Morphine; Synthroid; Oxycodone HCL; Nexium



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Pruritus, Hypersensitivity, Contusion, Chills, Headache, Herpes Zoster, Vascular Injury, Fatigue, Malaise, Tongue Disorder, Candidiasis, Scratch, Swelling Face, Vomiting, Tongue Oedema, Nausea, Anaemia, Hypoaesthesia, Rash, Dysgeusia, Diarrhoea, Feeling Abnormal, Influenza

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-05-04

Rebetol
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-05-04

Valtrex
    Dosage: unk unk, unknown
    Indication: Herpes Zoster

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-06-01



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Malaise, Vomiting, Nausea, Anaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-04-18

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-05-07

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-05-08
    End date: 2012-05-08

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-05-09
    End date: 2012-05-14

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-05-15

Telavic
    Dosage: 2250 mg, qd,cumulative dose 4500 mg
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-04-25

Telavic
    Dosage: 1000 unk, unk,cumulative dose 4500 mg
    Start date: 2012-06-13
    End date: 2012-07-09

Telavic
    Dosage: 1500 mg, qd,cumulative dose 4500 mg
    Administration route: Oral
    Start date: 2012-04-26
    End date: 2012-06-12

Other drugs received by patient: Motilium; Eurax; Allegra; Clobetasol Propionate; Predonine; Predonine



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Nausea, RED Blood Cell Count Decreased, Asthenia, Somnolence

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-02-23

Rebetol
    Dosage: 200 mg, bid
    Administration route: Oral

Rebetol
    Dosage: 400 mg,
    Indication: Hepatitis C
    Start date: 2012-02-23

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-03-22



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient:

Reactions: Nausea

Drug(s) suspected as cause:
Incivek
    Dosage: 2 df, q8h
    Administration route: Oral

PEG-Intron

Rebetol
    Administration route: Oral

Other drugs received by patient: Lorazepam; Ferrous Sulfate TAB; Levothyroxine Sodium; Tylenol



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Hepatitis C, Nausea, Anaemia, Rash, Headache, Dysgeusia, Irritability, Pruritus Generalised, Poor Quality Sleep, Malaise, Fatigue, Depression, Depressed Mood, Hypersomnia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.5 ml, unk
    Indication: Hepatitis C
    Start date: 2012-04-13

PEG-Intron
    Dosage: 0.4 ml, unk

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-13

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-11



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-23

Patient:

Reactions: Nausea, Erythema, Neutrophil Count Decreased, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-02-24

Rebetol
    Dosage: 800 mg, qd,cumulative dose:3200 mg
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-24
    End date: 2012-02-28

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-27
    End date: 2012-06-03

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Start date: 2012-03-02
    End date: 2012-03-26

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-24
    End date: 2012-02-28

Other drugs received by patient: Antebate; Loxonin; Valsartan; Lasix; Amino Acids (Unspecified); Norvasc; Lansoprazole; Allegra; Petrolatum; Aspirin; Humalog; Doxazosin Mesylate



Possible Rebetol side effects in

Reported by a pharmacist from United States on 2012-08-23

Patient:

Reactions: Nausea, Product Taste Abnormal

Drug(s) suspected as cause:
PEG-Intron

Rebetol
    Dosage: unk
    Administration route: Oral

Victrelis
    Dosage: 4 df, tid
    Administration route: Oral
    Indication: Hepatitis C



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Renal Impairment, Vomiting, Nausea, General Physical Health Deterioration, Dizziness

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Glycyron
    Dosage: 6 df, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-07-04

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-16

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-12

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-04-13
    End date: 2012-04-16

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-10
    End date: 2012-04-16

Other drugs received by patient: Nesina; Metformin HCL; Adalat CC; Doxazosin Mesylate; Amaryl; Amaryl; Kinedak; Allopurinol; Olmesartan Medoxomil; Trichlormethiazide; Loxonin; Primperan TAB; Adalat CC; Olmesartan Medoxomil; Vitamin B12; Loxonin; Doxazosin Mesylate; Kinedak; Loxonin; Loxonin; Potassium Chloride; Lyrica; Lendormin D; Adalat CC; Metformin HCL; Lendormin; Rohypnol; Electrolytes (Unspecified) (+) Sodium Lactate; Glycyron; Trichlormethiazide; Nesina; Urso 250; Vitamin E; Adalat CC



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Contusion, Head Discomfort, Somnolence, Fall, Abdominal Pain Upper, Loss of Consciousness, Fatigue, Dizziness, Blood Creatinine Increased, Migraine, Back Pain, Nausea, Hypotension, Convulsion, Eye Pain, Tremor

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-09

Rebetol
    Dosage: unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-09

Victrelis
    Dosage: unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-07



Possible Rebetol side effects in

Reported by a pharmacist from United States on 2012-08-22

Patient:

Reactions: Confusional State, Dyspnoea, Nausea, Anaemia, Rectal Haemorrhage, DRY Skin, Amnesia, Fatigue, Diarrhoea, DRY Mouth, Alopecia, Anorectal Discomfort, Depressed Mood, Injection Site Exfoliation, Aphonia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 180 microgram, qw, per injection

Rebetol
    Dosage: unk

Other drugs received by patient: Tricor; Micardis; Omega-3-Acid Ethyl Esters; Wellbutrin; Cardura; Vitamin E; Glucosamine



Possible Rebetol side effects in

Reported by a individual with unspecified qualification from Japan on 2012-08-22

Patient:

Reactions: Vomiting, Renal Disorder, Nausea

Drug(s) suspected as cause:
Investigational Drug (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-05
    End date: 2012-03-17

Investigational Drug (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-28
    End date: 2012-03-01

Investigational Drug (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-27
    End date: 2012-04-03

Investigational Drug (Unspecified)
    Dosage: 750 mg, qd
    Administration route: Oral
    Start date: 2012-04-04

PEG-Intron
    Dosage: 1.3mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-02-28

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Start date: 2012-02-24
    End date: 2012-02-24

Peginterferon Alfa-2B
    Dosage: 80 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-02-28

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-23

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-05
    End date: 2012-03-17

Rebetol
    Administration route: Oral
    Start date: 2012-02-24
    End date: 2012-02-27

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-28
    End date: 2012-03-01

Telavic
    Administration route: Oral
    Start date: 2012-02-24
    End date: 2012-02-26

Telavic
    Administration route: Oral
    Start date: 2012-03-27
    End date: 2012-04-03

Telavic
    Administration route: Oral
    Start date: 2012-04-04

Telavic
    Administration route: Oral
    Start date: 2012-03-05
    End date: 2012-03-17

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-28
    End date: 2012-03-01

Other drugs received by patient: Warfarin Sodium; Urso 250; Digoxin; Urso 250; Nizatidine; Efonidipine Hydrochloride Ethanolate; Nizatidine; Diovan



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Nausea

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-21
    End date: 2012-06-04

PEG-Intron
    Dosage: 1mcg/kg/week
    Start date: 2012-06-11
    End date: 2012-06-18

PEG-Intron
    Dosage: 0.8mcg/kg/week
    Start date: 2012-06-25

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-21
    End date: 2012-06-10

Rebetol
    Administration route: Oral
    Start date: 2012-06-11

Telavic
    Administration route: Oral
    Start date: 2012-07-02

Telavic
    Administration route: Oral
    Start date: 2012-06-11
    End date: 2012-07-01

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-21
    End date: 2012-06-10



Possible Rebetol side effects in

Reported by a individual with unspecified qualification from Japan on 2012-08-22

Patient:

Reactions: Haemoglobin Decreased, Nausea, Brain Abscess, Blood Uric Acid Increased, Blood Creatinine Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-02-24

Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-16
    End date: 2012-02-23

PEG-Intron
    Dosage: 80 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-01-16

PEG-Intron
    Dosage: 80 mcg/week
    Start date: 2012-01-16
    End date: 2012-05-07

Rebetol
    Dosage: 400 mg, once
    Administration route: Oral
    Start date: 2012-02-27
    End date: 2012-03-08

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-16

Rebetol
    Dosage: 400 mg, once
    Administration route: Oral
    Start date: 2012-04-16
    End date: 2012-04-22

Rebetol
    Dosage: 200 mg/2 days
    Administration route: Oral
    Start date: 2012-03-09
    End date: 2012-04-14

Rebetol
    Dosage: 600 mg, once
    Administration route: Oral
    Start date: 2012-01-16
    End date: 2012-02-26

Rebetol
    Dosage: 400 mg/2 days
    Administration route: Oral
    Start date: 2012-03-10
    End date: 2012-04-15

Rebetol
    Dosage: 600 mg, once
    Administration route: Oral
    Start date: 2012-04-23
    End date: 2012-05-13

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-16
    End date: 2012-02-23

Telavic
    Dosage: 1500 mg, once
    Administration route: Oral
    Start date: 2012-02-24
    End date: 2012-04-09

Other drugs received by patient: Carvedilol; Allegra; Carvedilol; Allegra; Diovan; Diovan; Naqua; [therapy Unspecified]; Trichlormethiazide



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-22

Patient:

Reactions: Weight Decreased, Visual Acuity Reduced, Weight Increased, Blood Calcium Decreased, Malaise, Fatigue, Skin Ulcer, Blood Count, Back Pain, Dyspnoea, Nausea, Anaemia, DRY Skin, Rash, Paraesthesia, Pollakiuria, Asthenia

Drug(s) suspected as cause:
Pegasys
    Dosage: 135 microgram, qw
    Start date: 2011-11-01
    End date: 2011-12-24

Pegasys
    Dosage: 180 microgram, qw
    Indication: Hepatitis C
    Start date: 2011-07-11

Rebetol
    Dosage: 800 mg, qd
    Start date: 2011-11-01
    End date: 2011-12-24

Rebetol
    Dosage: 600 mg, unk
    Start date: 2011-11-01
    End date: 2011-12-24

Rebetol
    Dosage: 1200, mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-07-11

Victrelis
    Dosage: 800 mg, tid
    Indication: Hepatitis C
    Start date: 2011-08-08



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Malaise, Nausea

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-21

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-21
    End date: 2012-06-17

Rebetol
    Administration route: Oral
    Start date: 2012-06-18

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-21
    End date: 2012-06-24

Telavic
    Administration route: Oral
    Start date: 2012-06-25

Other drugs received by patient: Voltaren; Mucosta



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Malaise, Nausea, Anaemia, Insomnia, Depression, Rash, Constipation, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-02-22

PEG-Intron
    Dosage: 1.0mcg/kg/week
    Start date: 2012-02-29
    End date: 2012-02-29

PEG-Intron
    Dosage: 0mcg/kg

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-02-14

Rebetol
    Administration route: Oral
    Start date: 2012-02-15
    End date: 2012-03-07

Rebetol
    Administration route: Oral

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-02-28

Telavic
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-03-07

Telavic
    Administration route: Oral

Other drugs received by patient: [therapy Unspecified]; [therapy Unspecified]; Milmag; Senna-Mint WAF; [therapy Unspecified]



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-21

Patient:

Reactions: Weight Decreased, Pneumonia, Pruritus, Nausea, Pyrexia, Headache, Suicidal Ideation, Eating Disorder, Insomnia, Depression, Decreased Appetite, Candidiasis

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Dosage: 180 microgram, qw
    Indication: Hepatitis C
    Start date: 2011-08-19
    End date: 2012-04-18

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-08-19

Victrelis
    Dosage: 4 df, tid

Victrelis
    Dosage: 40 mg, tid
    Administration route: Oral

Victrelis
    Dosage: 800 mg, tid
    Indication: Hepatitis C
    Start date: 2011-09-16

Victrelis
    Dosage: unk, tid
    Start date: 2011-08-19

Other drugs received by patient: Atarax; Diuretic (Unspecified); Xanax



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-15

Patient:

Reactions: Nausea, Anaemia, Platelet Count Decreased, Hyperuricaemia, Decreased Appetite

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-03-09
    End date: 2012-03-29

Peginterferon Alfa-2B
    Dosage: 1.2 ?g/kg, qw
    Start date: 2012-03-30
    End date: 2012-05-03

Peginterferon Alfa-2B
    Dosage: 0.9 ?g/kg, qw
    Start date: 2012-05-04
    End date: 2012-05-10

Peginterferon Alfa-2B
    Dosage: 1.2 ?g/kg, qw
    Start date: 2012-05-11
    End date: 2012-06-01

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-23

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    End date: 2012-06-01

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-03-19
    End date: 2012-03-22

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-09
    End date: 2012-03-18

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-16
    End date: 2012-05-17

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-09
    End date: 2012-03-15

Telavic
    Dosage: 750 mg, qd
    Administration route: Oral
    Start date: 2012-05-18
    End date: 2012-06-01

Other drugs received by patient: Urso 250; Allopurinol; Caduet; Novamine 15%



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017